ZELVYSIA
NDC 73289-0070, SAPROPTERIN DIHYDROCHLORIDE, powder, for solution, from Aucta Pharmaceuticals, Inc..
- Product NDC
- 73289-0070
- Status
- Listed
- Labeler
- Aucta Pharmaceuticals, Inc.
- Dosage form
- POWDER, FOR SOLUTION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA218645
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/73289-0070 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SAPROPTERIN DIHYDROCHLORIDE100 mg/1
Pharmacologic classes
Breast Cancer Resistance Protein Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]; Phenylalanine Hydroxylase Activator [EPC]; Phenylalanine Hydroxylase Activators [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 73289-0070-2 | 73289007002 | 30 PACKET in 1 CARTON (73289-0070-2) / 1 POWDER, FOR SOLUTION in 1 PACKET (73289-0070-1) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/8de84882-dd24-46f2-8416-5e492d4275d1
Use it
Look up 73289-0070 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/73289-0070 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 73289-0070. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.